SBOTF Financials 07/15/2014 19:46:36 Stellar Biot

SBOTF Financials 07/15/2014 19:46:36
Stellar Biotechnologies Inc.
Period Ending Aug 31, 2013 Aug 31, 2012 Aug 31, 2011 Sep 01, 2010
Total Revenue 545 286 697 -
Cost of Revenue 577 436 1,009 -
Gross Profit (31) (150) (312) -
Operating Expenses
Research and Development 1,446 1,826 826 -
Sales, General and Admin. 1,755 3,832 3,243 -
Non-Recurring Items 322 603 364 -
Other 125 112 87 -
Operating Income (3,678) (6,523) (4,832) -
Income From Continuing Operations
Add'l Income/Expense Items (11,207) 1,327 1,235 -
Earnings Before Interest and Tax (14,886) (5,196) (3,596) -
Interest Expense - - - -
Earnings Before Tax (14,886) (5,196) (3,596) -
Income Tax 1 1 1 -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (14,887) (5,197) (3,597) -
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (14,887) (5,197) (3,597) -
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (14,887) (5,197) (3,597) -